Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | THPO | P40225 | 1/20 | 0.52 |
| ▸ | MTOR | P42345 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | HBB | P68871 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | DPYD | Q12882 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4353311 | 0.81 | DPYD (0.50) | ALDH1A1LMNAMAPTCYP19A1TSHR | |
| SCHEMBL5800398 | 0.81 | — | — | |
| SCHEMBL161148 | 0.79 | ATAD2 (0.54) | ALDH1A1LMNAMAPTCYP19A1TSHR | |
| SCHEMBL2037916 | 0.77 | DPYD (0.46) | ALDH1A1LMNAMAPTCYP19A1TSHR | |
| SCHEMBL1916592 | 0.77 | DPYD (0.46) | ALDH1A1LMNAMAPTCYP19A1TSHR | |
| SCHEMBL5798297 | 0.77 | DPYD (0.46) | ALDH1A1LMNAMAPTCYP19A1TSHR | |
| SCHEMBL44459 | 0.77 | GAA (0.52) | ALDH1A1LMNAMAPTCYP19A1TSHR | |
| SCHEMBL2584919 | 0.77 | LMNA (0.52) | ALDH1A1LMNAMAPTCYP19A1TSHR | |
| SCHEMBL6555485 | 0.77 | DPYD (0.52) | ALDH1A1LMNAMAPTCYP19A1TSHR | |
| SCHEMBL190858 | 0.77 | ALDH1A1 (0.47) | ALDH1A1LMNAMAPTCYP19A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118931997-A | Method for synthesizing adenosine and/or uridine by three-enzyme cascade catalysis | 上海飞腾医药科技有限公司 | 2024-11-12 | — | — | CN | claimed |
| EP-0898575-B1 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KOESTER HUBERT DR (US) | 2004-12-29 | — | — | EP | claimed |
| US-20030194741-A1 | COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | CAPROTEC BIOANALYTICS GMBH (DE) | 2003-10-16 | — | — | US | claimed |
| EP-0898575-A2 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KÖSTER, Hubert (US) | 1999-03-03 | — | — | EP | claimed |
| WO-1997041139-A2 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KOESTER HUBERT (US) | 1997-11-06 | — | — | WO | claimed |
| CN-119775260-A | Pyrimidine-2, 4 (1H, 3H) -dione compounds, preparation method, pharmaceutical composition and application thereof | 中国医学科学院药物研究所 | 2025-04-08 | — | — | CN | disclosed |
| CN-118931997-A | Method for synthesizing adenosine and/or uridine by three-enzyme cascade catalysis | 上海飞腾医药科技有限公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-118165044-A | Stereoselective synthesis method and application of alpha-2' -deoxynucleoside | 中国药科大学 | 2024-06-11 | — | — | CN | disclosed |
| CN-115023268-A | Vaccination against antigens induced in cells infected by pathogens | 迈阿密大学 | 2022-09-06 | — | — | CN | disclosed |
| US-9636404-B2 | Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging | VISION GLOBAL HOLDINGS LTD. (CN) | 2017-05-02 | — | — | US | disclosed |
| US-20150204836-A1 | SOLUBLE METAL SENSOR COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2015-07-23 | — | — | US | disclosed |
| WO-2014036361-A2 | SOLUBLE METAL SENSOR COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2014-03-06 | — | — | WO | disclosed |
| US-5446137-A | Substituent selected from linking group containing modifiers such as biotin, reactive groups, nucleic acids, catalysts, DNA intercalators, minor groove binders, clevage agents, and detectable labels | SYNTEX (U.S.A.) INC. (US) | 1995-08-29 | — | — | US | disclosed |
| US-5192749-A | Viricide, AIDS | SYNTEX (U.S.A.) INC. (US) | 1993-03-09 | — | — | US | disclosed |
| EP-0457326-A1 | Antiviral agents | SYNTEX (U.S.A.) INC. (US) | 1991-11-21 | — | — | EP | disclosed |
| US-4762823-A | VIRICIDES, ANTICARCINOGENIC AGENTS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1988-08-09 | — | — | US | disclosed |
| US-4762823-A | VIRICIDES, ANTICARCINOGENIC AGENTS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1988-08-09 | — | — | US | disclosed |
| EP-0222192-A3 | NUCLEOSIDES OF 5-MONOFLUOROMETHYLURACIL AND 5-DIFLUOROMETHYLURACIL | Sloan-Kettering Institute For Cancer Research (US) | 1988-06-01 | — | — | EP | disclosed |
| EP-0222192-A2 | Nucleosides of 5-monofluoromethyluracil and 5-difluoromethyluracil | Sloan-Kettering Institute For Cancer Research (US) | 1987-05-20 | — | — | EP | disclosed |
| EP-0222192-A2 | Nucleosides of 5-monofluoromethyluracil and 5-difluoromethyluracil | Sloan-Kettering Institute For Cancer Research (US) | 1987-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030194741-A1 | COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | ADAR, RNMT, ATIC | ALDH1A1 4111/4885LMNA 2407/4885MAPT 2388/4885 |
| US-20150204836-A1 | SOLUBLE METAL SENSOR COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME | SOD1, CNBP, CACYBP | ALDH1A1 1164/4885LMNA 3303/4885MAPT 3641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.